📣 Calling all EU-based high-risk #MedicalDevice manufacturers: apply by 15 Sep 2023 to join Phase 2 of EMA's scientific advice pilot.
Prioritised devices include:
🩹 devices for rare conditions
⚕️ devices addressing unmet needs
🩺 novel devices with a major clinical impact

🐦🔗: https://n.respublicae.eu/EMA_News/status/1671886724962852871